ArticleJournal of personalized medicine2023
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence.
Open access · goldAbstract read
In one paragraph
Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
18.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer.Scientific reports · 2025Pooled it
- Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer.Oncology and therapy · 2026Review
- Bladder cancer patients hospitalized in a medicine ward including three fuo cases following bacillus calmette-guérin immunotherapy.The Canadian journal of urology · 2026Article
- AKAP7 is a prognostic biomarker involved in immune infiltration of bladder urothelial carcinoma and correlated with ferroptosis.Discover oncology · 2026Article
- De-Intensification Strategies in Non-Muscle-Invasive Bladder Cancer: Outcomes and Cost Impact of In-Office Bladder Fulguration.Journal of clinical medicine · 2026Article
- RAD54B as a biomarker for prognosis and immunotherapy response in bladder cancer.Discover oncology · 2026Article
- Bladder cancer-induced CVD mortality: Role of CAPG protein.PloS one · 2026Article
- Baicalin chemosensitivity enhancement of cisplatin in bladder cancer via autophagy flux inhibition.Frontiers in pharmacology · 2026Article
- Perioperative cognitive dysfunction in bladder cancer patients, causal factors, and possible interventions.Frontiers in medicine · 2026Review
- Treatment Pathway and Clinical Outcomes of the Population with Muscle-invasive Bladder Cancer in Italy: A Real-world Analysis with Administrative Databases.Advances in therapy · 2026Article
- Decoding SIGLEC12 in Bladder Cancer: In Silico Profiling of Expression, Tumor-Immune Interactions, and Prognostic Impact.Medicina (Kaunas, Lithuania) · 2025Article
- Liquid Biopsy: Current advancements in clinical practice for bladder cancer.The journal of liquid biopsy · 2025Review
- Exploring the Comparative Impact of Red and White Meat on Cardiovascular Diseases: A Global Cross-Sectional Ecological Study.Health science reports · 2025Article
- Diagnostic efficacy of [Discover oncology · 2025Article
- Integrated single-cell genomics, transcriptomics, and pathomics to identify potential biomarkers in muscle-invasive bladder cancer.Translational andrology and urology · 2025Article
- Usability Evaluation of Urinary HAI-1, STMN-1 and TN-C in the Diagnosis of Bladder Cancer.Journal of clinical medicine · 2025Article
- Significance of split-dose cisplatin-based neoadjuvant chemotherapy followed by robotic-assisted radical cystectomy for muscle invasive bladder cancer.Translational andrology and urology · 2025Article
- An Unusual Presentation of Bladder Carcinoma in a Visceral Hernia: A Case Report and Literature Review.Cancer reports (Hoboken, N.J.) · 2025Review
- Transurethral resection of ureteral tumors at the intramural segment: A pilot study.Bladder (San Francisco, Calif.) · 2025Article
- The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.Nutrition and cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 6 institutions in 2 countries.
Biagio BaroneDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-4884-132X
Marco FinatiDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0002-7425-1166
Francesco CinelliDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Antonio FanelliDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Francesco Del GiudiceDepartment of Maternal-Infant and Urological Sciences, Sapienza Rome University, 00185 Rome, Italy.ORCID 0000-0003-3865-5988
Ettore De BerardinisDepartment of Maternal-Infant and Urological Sciences, Sapienza Rome University, 00185 Rome, Italy.
Alessandro SciarraDepartment of Maternal-Infant and Urological Sciences, Sapienza Rome University, 00185 Rome, Italy.ORCID 0000-0002-7899-8056
Gianluca RussoDepartment of Public Health, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-2698-9470
Vito ManciniDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Nicola D'AltiliaDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Matteo FerroDepartment of Urology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.ORCID 0000-0002-9250-7858
Angelo PorrecaOncological Urology, Veneto Institute of Oncology (IOV) IRCCS, 35128 Padua, Italy.
Benjamin I ChungDepartment of Urology, Stanford Medical Center, Stanford, CA 94305, USA.
Satvir BasranDepartment of Urology, Stanford Medical Center, Stanford, CA 94305, USA.ORCID 0000-0003-4744-2853
Carlo BettocchiDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Luigi CormioDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Ciro ImbimboDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.
Giuseppe CarrieriDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.
Felice CrocettoDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-4315-7660
Gian Maria BusettoDepartment of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0002-7291-0316
University of Foggia · ITUniversity of Naples Federico II · ITSapienza University of Rome · ITStanford Medicine · USIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Oncologico Veneto · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
bladder cancercardiovascular diseasecomorbiditiesrisk factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.